UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 8-K

Current Report Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): ~~June~~April 2829, ~~2007~~2008

CryoCor, Inc.

(Exact name of registrant as specified in its charter)

Delaware	000-51410	33-0922667
(State or other jurisdiction of incorporation)	(Commission File Number)	(I.R.S. Employer Identification No.)
(State or other jurisdictionof incorporation)	(Commission File Number)	(I.R.S. EmployerIdentification No.)

9717 Pacific Heights Boulevard

San Diego, California

92121

(Address of principal executive offices)

(Zip Code)

Registrant’s telephone number, including area code: (858) 909-2200

Not Applicable.

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

¨	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 52.02. ~~Departure~~Results of ~~Directors~~Operations orand ~~Principal~~Financial ~~Officers; Election of Directors; Appointment of Principal Officers; Compensatory Arrangements of Certain Officers~~Condition.

On ~~June~~April 2829, ~~2007~~ 2008, ~~the~~we ~~Compensation~~announced ~~Committee~~the amounts of our ~~Board~~cash, ofcash ~~Directors~~equivalents ~~(the~~and ~~“Compensation~~investments ~~Committee”) approved~~as ~~revisions~~well toas ~~certain~~total ~~corporate~~debt ~~goals~~outstanding ~~for~~under ~~2007 in connection with the annual bonus for Dr. Helen S. Barold,~~ our ~~Chief~~senior ~~Medical~~debt ~~Officer.~~facility ~~Subsequently,~~as onof ~~July 3,~~certain ~~2007,~~dates ~~the~~in ~~Compensation Committee superseded~~ the ~~above~~“Recommendation ~~referenced approval~~– ~~and~~Background ~~approved~~of aOffer” ~~bonus~~section ~~award~~ of ~~$100,000 to be paid to Dr.~~Item ~~Barold~~4 ~~in recognition~~ of a ~~her~~Solicitation/Recommendation ~~work~~Statement on ~~our~~Schedule ~~behalf~~14D-9 infiled ~~connection~~by us with the ~~U.S.~~Securities ~~Food~~ and ~~Drug~~Exchange ~~Administration’s~~Commission (the “~~FDA~~SEC”) ~~Advisory Panel meeting held on June 27~~, ~~2007~~ ~~and~~which ~~the~~is ~~FDA’s~~attached ~~review~~hereto ofas ~~our~~Exhibit ~~application~~99.1 ~~for~~and ~~pre-market~~incorporated ~~approval~~herein ~~relating~~by ~~to the treatment of atrial flutter~~reference.

The information in this Item 2.02 is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities and Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in this Item 2.02 shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended.

Item 9.01.

Financial Statements and Exhibits.

(d)

Exhibits.



99.1		Solicitation/Recommendation Statement on Schedule 14D-9 filed with the SEC on April 29, 2008.(1)

(1)	Incorporated by reference to our Solicitation/Recommendation Statement on Schedule 14D-9 filed with the SEC on April 29, 2008.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


CryoCor, Inc.

By:		/s/ Gregory J. Tibbitts
		Gregory J. Tibbitts
		Vice President, Finance and Chief Financial Officer (Principal Financial and Accounting Officer)

Date: ~~July~~April 529, ~~2007~~2008

INDEX TO EXHIBITS



99.1		Solicitation/Recommendation Statement on Schedule 14D-9 filed with the SEC on April 29, 2008.(1)

(1)	Incorporated by reference to our Solicitation/Recommendation Statement on Schedule 14D-9 filed with the SEC on April 29, 2008.

Filing Compare · CRYOCOR INC